The divergence between D.E. Shaw (accumulating) and Citadel (reducing) signals high uncertainty around ZNTL's pipeline milestones. With 60% analyst bullishness but 13F lag, traders should watch for upcoming clinical data readouts as the next catalyst to resolve the directional debate.
ZNTL drugs
ZNTL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $3.75entry
- T+1 · 5mo ago +0.80%α −0.96% · $3.78
- T+5 · 5mo ago −1.33%α −2.01% · $3.70
- T+20 · 4mo ago +30.13%α +28.35% · $4.88
- T+60 · 2mo ago +7.47%α +4.20% · $4.03
How similar events traded
Executive Summary
Institutional cluster for ZNTL in Q3 2024 reveals a mixed picture: D.E. Shaw doubled its position to $4.2M and Balyasny added, while Citadel trimmed 40% of its large $18.4M stake and Legal & General nearly exited. Net outflow of ~$5.2M from tracked institutions, but the active manager buying (D.E. Shaw, Balyasny) suggests some conviction ahead of upcoming catalysts.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$5.2M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| D.E. Shaw | DOUBLED | +369.6% | $4.2M | $3.2M |
| Voya Investment Management | DOUBLED | +159.6% | $184.0K | $105.0K |
| Balyasny Asset Management | ADD | +70.8% | $253.0K | $88.0K |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Citadel | TRIM | -39.6% | $18.4M | -$8.4M |
| Legal & General Group | NEAR_EXIT | -90.7% | $218.0K | -$199.9K |
Key Facts
- 3 institutions accumulated $4.6M (net +$3.4M) while 2 institutions sold $8.6M net
- D.E. Shaw (quant) DOUBLED its stake to 1.13M shares worth $4.2M, a $3.2M increase
- Citadel (quant) trimmed 39.6% of its position, selling ~1.79M shares worth $8.4M
- Balyasny Asset Management added 70.8% to its position, now 68.7K shares
- Legal & General Group (passive) nearly fully exited, reducing from $218K to $18K
- Net dollar flow: sellers outsize buyers $8.6M to $3.4M
Financial Impact
Net institutional outflow of ~$5.2M, driven by Citadel's $8.4M reduction partially offset by D.E. Shaw's $3.2M accumulation
Risk Factors
- 13F data reflects quarter-end positions with a 45-day lag; cluster may have been unwound
- Clinical-stage biotech binary risk from pipeline failures
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ZNTL-2024-Q3 |
Track record
18 reports on ZNTL
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +51.42% at T+60 after the Aug 14, 2026 report. 6 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 4/10 Entry $1.62 settles Feb 12
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.80 settles Feb 8
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $2.06 settles Jan 26
- Oct 18, 202629d ago Press Release Bullish 7/10 Entry $2.30 settles Jan 14
- Oct 1, 20266w ago Press Release Neutral 2/10 Entry $2.52 settles Dec 29
- Aug 14, 202613w ago 8-K Bearish 6/10 Entry $3.71 to $1.80 ▲ +51.42% +48.47% vs SPY
- Aug 13, 202613w ago Press Release Bearish 6/10 Entry $3.56 to $1.74 ▲ +51.12% +48.08% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Viewing Entry $3.75 to $4.03 ▲ +7.47% +4.20% vs SPY
- Jun 1, 202624w ago Press Release Neutral 2/10 Entry $3.95 to $3.89 ▼ −1.52% −2.64% vs SPY
- May 21, 202625w ago Press Release Bullish 6/10 Entry $4.06 to $3.68 ▼ −9.36% −12.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers